Completed NCT00938743
This summary needs review. Please check the official study record and contact the research team for details.
In Mannheim Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 18 Years to 55 Years
Countries Germany
Sponsor Central Institute of Mental Health, Mannheim
Condition ADHD Completed NCT00807222
This summary needs review. Please check the official study record and contact the research team for details.
In Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Clinical Study Centers, LLC
Condition ADHD Completed NCT00291070
This summary needs review. Please check the official study record and contact the research team for details.
In Coquitlam Why is this study shown? This study is directly about ADHD.
ADHD Drug From 8 Years to 12 Years
Countries Canada
Sponsor University of British Columbia
Condition ADHD Completed NCT00409708
This summary needs review. Please check the official study record and contact the research team for details.
In Houston Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Novartis
Condition ADHD Completed NCT01439126
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 17 Years
Countries
Sponsor Concordia Pharmaceuticals Inc., Barbados
Condition ADHD Completed NCT00482313
This summary needs review. Please check the official study record and contact the research team for details.
In Huddinge Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 65 Years
Countries Sweden
Sponsor Psychiatry Karolinska
Condition ADHD Completed NCT00191945
This study is completed in Spain. It is testing atomoxetine for ADHD.
Multiple locations, including Badajoz Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 15 Years
Countries Spain
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00776009
This study is completed in the United States. It is testing Dex-Methylphenidate Extended Release 30 mg Versus 20 mg for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Novartis Pharmaceuticals
Condition ADHD Withdrawn NCT01207622
This summary needs review. Please check the official study record and contact the research team for details.
In Cambridge Why is this study shown? This study is directly about ADHD.
ADHD, Addiction Drug From 15 Years to 30 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD, Addiction Completed NCT01270555
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD, Addiction Drug From 18 Years to 60 Years
Countries
Sponsor Massachusetts General Hospital
Condition ADHD, Addiction Completed NCT00318448
This study is completed in the United States and in Canada. It focuses on ADHD.
Multiple locations, including Bridgewater Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 17 Years
Countries United States, Canada
Sponsor Sanofi
Condition ADHD Withdrawn NCT02154321
This summary needs review. Please check the official study record and contact the research team for details.
In Ann Arbor Why is this study shown? This study is directly about ADHD.
ADHD Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 35 Years
Countries United States
Sponsor University of Michigan
Condition ADHD